These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 28434332)

  • 41. Comparison of clinical features in transient focal neurological episodes between hereditary transthyretin type and Aβ type cerebral amyloid angiopathy.
    Nakajima M; Takeuchi Y; Nagao Y; Masuda T; Yamashita T; Yonehara T; Terasaki T; Ando Y
    Amyloid; 2019; 26(sup1):81-82. PubMed ID: 31343286
    [No Abstract]   [Full Text] [Related]  

  • 42. Late-onset and fast progressive neuropathy and cardiomyopathy in Val32Ala transthyretin gene mutation.
    Cazzato D; Dalla Bella E; Saveri P; Taroni F; Marucci G; Lauria G
    Neurol Sci; 2019 Jun; 40(6):1267-1269. PubMed ID: 30685801
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Common clinicopathological features in late-onset hereditary transthyretin amyloidosis (Ala97Gly, Val94Gly and Val30Met).
    Koike H; Nakamura T; Nishi R; Ikeda S; Kawagashira Y; Iijima M; Yasuda T; Mukai E; Date Y; Shiomi K; Nakazato M; Katsuno M; Sobue G
    Amyloid; 2019; 26(sup1):24-25. PubMed ID: 31343348
    [No Abstract]   [Full Text] [Related]  

  • 44. Delayed diagnosis of transthyretin amyloidosis with a novel mutation (c.210T>A) in the transthyretin gene.
    Dekmezian MS; Tschen JA; Cho-Vega JH
    J Am Acad Dermatol; 2013 Feb; 68(2):e49-51. PubMed ID: 23317988
    [No Abstract]   [Full Text] [Related]  

  • 45. Effect of doxycycline and ursodeoxycholic acid on transthyretin amyloidosis.
    Wixner J; Pilebro B; Lundgren HE; Olsson M; Anan I
    Amyloid; 2017 Mar; 24(sup1):78-79. PubMed ID: 28042702
    [No Abstract]   [Full Text] [Related]  

  • 46. Cardiac phenotype and clinical outcome of familial amyloid polyneuropathy associated with transthyretin alanine 60 variant.
    Sattianayagam PT; Hahn AF; Whelan CJ; Gibbs SD; Pinney JH; Stangou AJ; Rowczenio D; Pflugfelder PW; Fox Z; Lachmann HJ; Wechalekar AD; Hawkins PN; Gillmore JD
    Eur Heart J; 2012 May; 33(9):1120-7. PubMed ID: 21992998
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hereditary transthyretin amyloidosis: baseline characteristics of patients in the NEURO-TTR trial.
    Waddington-Cruz M; Ackermann EJ; Polydefkis M; Heitner SB; Dyck PJ; Barroso FA; Wang AK; Berk JL; Dyck PJB; Monia BP; Hughes SG; Tai L; Jesse Kwoh T; Jung SW; Coelho T; Benson MD; Gertz MA
    Amyloid; 2018 Sep; 25(3):180-188. PubMed ID: 30169969
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Unexplained cardiac failure leading to the identification of a Belgian family affected by hereditary amyloidosis.
    De Pasqual A; Biessaux Y; Blettard N; Crémers S; Caers J
    Acta Clin Belg; 2013; 68(4):303-5. PubMed ID: 24455802
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Amyloid Polyneuropathy and Myocardial Amyloidosis 10 Years after Domino Liver Transplantation from a Patient with a Transthyretin Ser50Arg Mutation.
    Matsushima M; Yabe I; Tsuda M; Sakakibara M; Shimamura T; Sasaki H
    Intern Med; 2017 Dec; 56(23):3231-3235. PubMed ID: 28943540
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Progressive Multiple Mononeuropathy in a Patient With Familial Transthyretin Amyloidosis After Liver Transplantation.
    Seibert K; Wlodarski R; Sarswat N; Appelbaum D; Issa NP; Soliven B; Rezania K
    J Clin Neuromuscul Dis; 2022 Mar; 23(3):143-147. PubMed ID: 35188911
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Wild-Type Transthyretin Cardiac Amyloidosis Is Associated with Increased Antecedent Physical Activity.
    Lee YZJ; Fajardo J; Brown E; D'Adamo CR; Judge DP
    J Cardiovasc Transl Res; 2022 Aug; 15(4):689-691. PubMed ID: 35083733
    [No Abstract]   [Full Text] [Related]  

  • 52. Clinical manifestations in hereditary amyloidosis with the variant Glu54Gln transthyretin.
    Jercan A; Badelita S; Draghici M; Stoica E; Iacob S; Coriu D
    Amyloid; 2019; 26(sup1):31-32. PubMed ID: 31343281
    [No Abstract]   [Full Text] [Related]  

  • 53. [Transthyretin-related amyloidotic cardiomyopathy: looking for the etiological treatment].
    Longhi S; Gagliardi C; Milandri A; Manuzzi L; Rapezzi C
    G Ital Cardiol (Rome); 2014 May; 15(5):293-300. PubMed ID: 25002169
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Origin of sporadic late-onset hereditary ATTR Val30Met amyloidosis in Japan.
    Ueda M; Yamashita T; Misumi Y; Masuda T; Ando Y
    Amyloid; 2018 Sep; 25(3):143-147. PubMed ID: 30486687
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Systemic angiopathy and axonopathy in hereditary transthyretin amyloidosis with Ala97Gly (p. Ala117Gly) mutation: a post-mortem analysis.
    Koike H; Yasuda T; Nishi R; Ikeda S; Kawagashira Y; Iijima M; Sobue G; Katsuno M
    Amyloid; 2018 Jun; 25(2):141-142. PubMed ID: 29855203
    [No Abstract]   [Full Text] [Related]  

  • 56. Treatment of transthyretin cardiomyopathy with a TTR-specific antisense oligonucleotide (IONIS-TTR
    Benson MD; Ackermann EJ; Monia BP
    Amyloid; 2017 Mar; 24(sup1):134-135. PubMed ID: 28434337
    [No Abstract]   [Full Text] [Related]  

  • 57. First report of a rare mutation in a Polish patient with painful late-onset transthyretin amyloidosis.
    Hagenacker T; Brenck J; Kastrup O
    J Neurol Sci; 2014 Nov; 346(1-2):331-2. PubMed ID: 25130926
    [No Abstract]   [Full Text] [Related]  

  • 58. Cardiac Amyloidosis in a Child Presenting with Syncope: The First Reported Case and a Diagnostic Dilemma.
    Torpoco Rivera DM; Williams CT; Karpawich PP
    Pediatr Cardiol; 2022 Mar; 43(3):700-703. PubMed ID: 34783874
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Vitreal deposits in Val71Ala transthyretin amyloidosis.
    Suan D; Booth DR; Kennedy IH; Downie J; Earls P; Gottlieb D; Stewart GJ; Lin MW
    Intern Med J; 2012 Jan; 42(1):106-8. PubMed ID: 22276564
    [No Abstract]   [Full Text] [Related]  

  • 60. Rapidly Progressive Transthyretin-Mediated Amyloidosis in a Domino Liver Transplant Recipient of a Ser23Asn Donor.
    Dixit N; Castano A; Farr MJ; Traub R; Lentzsch S; Brown RS; Maurer MS; Brannagan TH
    J Clin Neuromuscul Dis; 2016 Mar; 17(3):142-5. PubMed ID: 26905915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.